Trial Profile
Canadian Observation Trial in CF Patients Undergoing Treatment With Ivacaftor
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Ivacaftor (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- Acronyms G551D
- 08 Jan 2018 New trial record